This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Curis, Inc., Harvard College. Active years: 2010-2013.
Location History:
- Lowell, MA (US) (2010 - 2013)
- Waltham, MA (US) (2013)
Company Filing History:
Years Active: 2010-2013
Title: Carmen Pepicelli: Innovator in Cancer Treatment
Introduction
Carmen Pepicelli is a notable inventor based in Lowell, MA (US), recognized for his contributions to cancer treatment through innovative methodologies. With a total of 4 patents, Pepicelli has made significant strides in the field of biotechnology, particularly in inhibiting unwanted cell proliferation.
Latest Patents
Among his latest patents, Pepicelli has developed methods for inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling. This application focuses on compositions and methods for inhibiting angiogenesis and treating or preventing unwanted cell proliferation, including tumors, by targeting the hedgehog pathway. Another significant patent involves methods of treating pancreatic or liver cancer using hedgehog antagonists, which also aims to inhibit angiogenesis and unwanted cell proliferation through similar mechanisms.
Career Highlights
Throughout his career, Pepicelli has worked with esteemed organizations such as Curis, Inc. and Harvard College. His work has been pivotal in advancing the understanding and treatment of various cancers, showcasing his dedication to medical innovation.
Collaborations
Carmen Pepicelli has collaborated with notable colleagues, including Henryk T Dudek and Irina Karavanov, who have contributed to his research endeavors.
Conclusion
Carmen Pepicelli's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in biotechnology and cancer therapies.